Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Drug Manufacturers - Specialty & Generic

Healthcare
$6.57 -1.07%

-$0.06 today

Market cap
$98.52M
Beta
0.10
P/E (TTM)
-11.5
EPS (TTM)
-$0.48
52W Low $1.85High $6.61

Volume 0.16M

Average 0.97M

CPIX Pre-Tax Margin

Income before tax as a percentage of revenue.

Cumberland Pharmaceuticals Inc.NASDAQ: CPIX

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -34.4%

Pre-tax margin was -34.4% in Q1 FY2026, down 45.1 pp from a year earlier. On a trailing-twelve-month basis it was -17.2%, down 9.1 pp year over year. Over 3 fiscal years it widened by 6.9 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-34.4%-24.1 pp QoQ
Last fiscal yearDec 2025
-6.3%+10.7 pp YoY
LTMMar 2026
-17.2%-9.1 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-45.1 pp——
1 year+10.7 pp——
3 years+6.9 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-6.3%
Year-over-year change
+10.7pp

Pre-Tax Margin vs competitors

How CPIX compares with its peers on the latest reported figures

  • CPIX's LTM Mar 2026 pre-tax margin of -17.2% is the highest of the 3 companies compared; the peer median is -295.3%.
  • Its year-over-year change of -9.1 pp is the highest of 3, against a peer median of -154.8 pp.
  • Over three fiscal years its change of +6.9 pp compares with a peer median of -344.9 pp.
CPIX Competitors Peer median
Pre-Tax Margin for CPIX and competitors
Company Period LTM level YoY 3-year change
CPIXCumberland Pharmaceuticals Inc.LTM Mar 2026-17.2% -9.1 pp+6.9 pp
DYAIDyadic International, Inc.LTM Mar 2026-245.1% -70.9 pp-265.4 pp
CELUCelularity Inc.LTM Dec 2025-345.4% -238.7 pp-424.5 pp
LTRNLantern Pharma Inc.FY2025— ——
Peer median (excluding CPIX) -295.3%-154.8 pp-344.9 pp

Competitors are the stored peer set for CPIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue35.99M42.01M39.55M37.87M44.52M
Cost of Revenue8.81M9.12M6.07M6.59M6.67M
Gross Profit27.17M32.89M33.49M31.28M37.85M
Gross Margin75.5%78.3%84.7%82.6%85.0%
Research & Development5.68M6.69M5.83M4.82M5.57M
Selling, General & Admin24.8M26.84M29.1M28.15M31.05M
Operating Expenses34.85M38.6M43.04M37.71M40.65M
Depreciation & Amortization4.61M5.33M8.1M6.04M5.29M
EBITDA(857.83K)332.92K2.49M182.42K2.96M
EBITDA Margin-2.4%0.8%6.3%0.5%6.6%
Operating Income(7.68M)(5.7M)(9.55M)(6.43M)(2.79M)
Operating Margin-21.3%-13.6%-24.2%-17.0%-6.3%
Interest Income26.08K98.41K286.85K334.44K476.75K
Interest Expense98.03K586K667.86K605.51K495.99K
Other Income / Expenses2.12M123.74K3.27M(33.98K)(32.46K)
Income Before Tax(5.56M)(5.58M)(6.28M)(6.47M)(2.82M)
Pre-Tax Margin-15.5%-13.3%-15.9%-17.1%-6.3%
Income Tax Expense34.89K68.85K45.77K(22.67K)40.26K
Net Income(3.51M)(5.57M)(6.28M)(6.48M)(2.84M)
Net Margin-9.7%-13.3%-15.9%-17.1%-6.4%
EPS (Basic)(0.24)(0.38)(0.44)(0.46)(0.19)
EPS (Diluted)(0.24)(0.38)(0.44)(0.46)(0.19)
Weighted Avg Shares14.9M14.56M14.3M14.06M14.96M
Weighted Avg Shares (Diluted)14.9M14.56M14.3M14.06M14.96M

Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Intrinsic Alpha fair value

Locked

Current Price

$6.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.